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It  is  well  established  that  tumor  cells  express  unique  antigens  not  present  on 
nontransformed cells. Although this fact has been amply documented in a  variety of 
in  vivo  and  in  vitro  assay  systems  (1-3),  there  has  yet  been  no  clue  as  to  the 
biochemical identity of the putative tumor-specific transplantation  antigen  (TSTA). 
Our laboratory has been interested  for some time in the biochemical elucidation  of 
the unique antigens on tumor cells. Attempts have been made to purify and solubilize 
the plasma membrane as a first step to isolate the TSTA (4). Having established that 
the TSTA copurifies with plasma membrane and can be solubilized in an active form 
by  detergent,  we  began  to  investigate  if it  was  possible  to  induce  tumor-specific 
cytotoxic lymphocytes in a syngeneic secondary in vitro stimulation. Success with this 
technique should enable us to study the relationship between the antigens recognized 
in  in  vitro cytotoxicity assays and  those  inducing  tumor rejection  activity in  vivo. 
Recently, serologically active detergent solubilization of the major histocompatibility 
(H-2) antigens was achieved (5-8)  and also shown to be capable of eliciting in vitro 
allogeneic responses (9,  10). In this report, we demonstrate the feasibility of inducing 
cytotoxic effector lymphocytes in a syngeneic tumor system with purified, detergent- 
solubilized plasma membrane. 
Materials and Methods 
Mice.  Adult female [(BALB/c x  C57BL/6)]FI (CBF1) mice were purchased from Charles 
River Breeding Laboratories, Wilmington, Mass. 
Tumor-Cell Lines.  RBL-5 is a lymphoma induced by Rauscher murine leukemia virus; it has 
strong cross-reacting antigens with other Friend-Moloney-Rauscher (FMR)-induced lympho- 
mas. It is maintained either in  ascitic  form in  female C57BL/6  (B6) mice or in  vitro as a 
continuous suspension  culture. Eo~2 is a Gross-murine leukemia virus-induced lymphoma and 
MBL-2, a Moloney leukemia virus-induced lymphoma; both are also maintained in B6 mice. 
mKSA is  an  undifferentiated  sarcoma induced  by SV40  in  BALB/c  mice and  EL-4  is  a 
chemically-induced lymphoma, syngeneic  to B6 mice. mKSA, EO~2, and EL-4 do not cross- 
react with RBL-5. 
Plasma Membrane Purification.  The purification scheme for RBL-5 plasma membrane was 
essentially  as  described  by Snary et  al.  (11) and  as adapted  by Rogers et  al.  (4). Plasma 
b  membrane yield was based on histoeompatibility antigen (H-2) which has been shown to be 
expressed  almost exclusively on the plasma membrane (PM).  Solubilization was done in 0.14 
M  NaCI, 0.01 M  Na phosphate, pH 8.0  (PBS) containing 2% sodium deoxycholate (DOC). 
Insoluble material was removed by centrifugation at  100,000 g for 45  min;  the solubilized 
plasma membrane (SPM)  was filter sterilized  and stored at  -20°C  until  used.  The mKSA 
plasma membrane preparation was that described  by Rogers et al.  (4) and had good tumor 
specific rejection activity. 
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Secondary In  Vitro Sensitization of Spleen Cells.  Responding spleen cells were obtained from 
mice that had previously rejected a subcutaneous challenge of 5 ×  105 RBL-5 tumor cells after 
prior immunization with two doses of 50 ~g/ml solubilized plasma membrane antigens. The 
immune  spleen cells were cultured alone, as control,  or with  (a)  purified RBL-5  vesicular 
plasma membrane, (b) purified plasma membrane solubilized with 2% DO(3 or (c) mitomycin 
C-inactivated RBL-5 tissue culture cells. Mitomycin C  (60 #g/ml) inactivation was performed 
at 37°C  for 20  min and the cells were then washed three times in Eagles' minimal essential 
medium before culture. After each wash, cells were allowed to incubate for  10 rain at 370C. 
Cultures were established in 30 ml RPMI-1640 (Grand Island Biological Co., Grand Island, N. 
Y.) consisting of 40  ×  106 responding cells and 4  ×  105 stimulating cells, or PM, particulate or 
solubilized, at concentrations indicated in the text. RPMI-1640 supplemented with 5  ×  10  -5 
M  2-mercaptoethanol,  10%  fetal calf serum  (FCS)  (heat inactivated),  1% fresh L-glutamine, 
and 1% penicillin-streptomycin, was used. Cultures were established in tissue culture flasks and 
incubated at 37°C in a humidified chamber with air containing 5% CO2 for 5 days. 
Anti-O Antibody.  AKR anti-Thy 1.2 C3H antibody was provided by Dr. H. Holden, National 
Cancer Institute. The preparation and activity of this antiserum has been reported elsewhere 
in detail (12). 
Target Cell Labeling.  All target cells were labeled with 5~Cr by incubating 3-6  ×  106 cells 
with 200/~Ci of [51Cr]NaCrO4  (New England Nuclear, Boston, Mass.) for 1 h in PBS. 
Cell-Mediated Cytotoxicity Assay.  The standard 5XCr-release assay involved the incubation of 
1 ×  10451Cr-labeledtarget cells with3  ×  105 ,  1 ×  105 , and  1 ×  104effectorcellsin0.2ml 
RPMI-1640 containing 10% FCS for 4 h at 37°C. Percentage of cytotoxicity was defined as: 
Se-So 
×  100 
Sin-So 
where Se -- isotope release from wells containing effector cells plus targets, So -- spontaneous 
release of isotope from wells containing target cells plus medium, Sm  -  maximum isotope- 
release after 3 cycles of freezing and thawing of target cells. Percentage of specific cytotoxicity 
-~ percent cytotoxicity of immune cells cultured with stimulating antigen-percent cytotoxicity 
of immune cells cultured alone. 
Results 
Induction  of Cytotoxic  Lymphocytes  by  Purified  Plasma  Membrane.  Although  we  have 
established  that  as  low  as  2  /~g of purified  RBL-5  plasma membrane,  both  in  the 
particulate  and  solubilized  forms,  was  capable  of  inducing  immunity  against  a 
subcutaneous  challenge of viable tumor  cells, it  was  not  known  whether  this same 
antigen(s)  could  induce  cytotoxic lymphocytes in  vitro. To  test if this was  possible, 
RBL-5 immune lymphocytes were incubated with inactivated RBL-5 leukemia cells, 
1 /~g/ml PM  or  1/~g/ml SPM.  The final concentration of DOC  in the cultures was 
1.2/~g/ml. After 5 days stimulation cytotoxicity was determined and the results (Fig. 
1)  clearly indicated that  syngeneic tumor cell PM,  particulate or solubilized with  a 
modest amount of detergent, was fully capable of inducing a  secondary generation of 
cytotoxic lymphocytes. There appeared to be little or no difference in the efficiency 
of the tumor antigens before or after detergent solubilization. In at least four different 
experiments  (Fig.  1, Table I), the induction of cytolytic lymphocytes by  1 /~g/ml of 
tumor PM  or SPM was nearly as efficient as an equivalent number of intact tumor 
cells. 
Specificity  of the Induction  Phase  by PM and SPM.  All cultures tested, including the 
controls, contained the same amount of DOC. However, to be certain that nothing in 
our membrane preparation was causing nonspecific stimulation, normal unimmunized 
spleen cells were incubated with RBL-5 cells, PM, or SPM. In all cases, cytotoxic cells 
could  not  be  generated  (Fig.  1).  Likewise, incubation  of RBL-5  immune  cells with ALABA  AND  LAW 
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FIO.  1.  Cytotoxic activity of immune spleen cells (  ) or normal spleen cells (- - -) restimulated 
in vitro with mitomycin C-inactivated RBL-5 tumor cells (©), 1 #g/ml plasma membrane (I-1),  and 
1 #g/ml DOC solubilized plasma membrane (A). 
TAnLE I 
Induction of Cytotoxic Effector Cells by Whole Cells, PM, and Solubilized PM 
Stimulating antigen  RBL-5 cells 
%Specificlty cytotoxiclty 
Plasma membrane  (1  Solubilized plasma mem- 
#g/m])  brane  (1 #g/ml) 
E.ffl"*  30  10  30  10  30  10 
Exp. 1  58  21  49  16  53  19 
Exp. 2  71  38  66  30  70  33 
Exp. 3  62  40  60  34  60  36 
* E/T, effector cell:target cell ratio. 
purified PM or SPM of the mKSA tumor induced no cytotoxic effector cells capable 
of lysing RBL-5 targets (data not shown). 
Titration of  Induction by PM and SPM.  The dose response for the secondary generation 
of cytotoxic effector cells  by PM  and  SPM  was determined  by incubating  graded 
doses of the antigen  with  RBL-5 immune lymphocytes. A  concentration-dependent 
effect was observed in  both cases  (Fig.  2).  Induction  of cytotoxic cells was possible 
with a concentration as low as 0.5 #g/ml of PM or SPM. 
Specificity of the  Cytotoxic Reaction.  In  initial  experiments,  we have observed  that 
effector cells generated in the presence of inactivated tumor cells maintained a strict 
specificity  for  RBL-5  and  for  the  Moloney  virus-transformed  lymphoma,  MBL-2. 
Similar results were also obtained with  PM and SPM  (Table II). The effector cells 
generated by PM and SPM significantly lysed RBL-5 and MBL-2 tumor cells (FMR 
cross-reactivity) although EdG2, a syngeneie Gross virus-induced lymphoma was not 
lysed. EL-4 lysis was only marginal. 
The cytotoxic effector cells generated  were found,  in  all cases,  to be sensitive to 
treatment  with  anti-0  antiserum  plus  complement,  but  not  to  complement  alone, 
suggesting that the effector cells are T  lymphocytes. 
Discussion 
The purpose of the present  study was to investigate the possibility of generating 
syngeneic tumor-specific cytotoxic effector cells with particulate and solubilized PM. 
Although studies on in vitro stimulation of allogeneic effector cells with histoincom- 
patible plasma membranes have been previously reported (5-10), we are aware of no 
attempt  to stimulate  specifically syngeneic effector cells with  PM  or SPM.  In  this 1438  ALABA  AND  LAW  BRIEF  DEFINITIVE  REPORT 
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FIG.  2.  Dose dependence of CTL induction. Graded amounts ofplasma membrane (  ) or DOC 
solubilized plasma membrane (---)  were added to cultures of RBL-5 immune spleen cells at  5 
p,g/ml (O),  1/.tg/ml (&), and 0.5/.tg/ml  (m). Final concentration of DOC  in the cultures ranged 
from 6.0 to 0.6 #g/ml, respectively. 
TABLE  II 
Specificity of CTL Generation by RBL-5 Cells, Plasma Membrane, and Solubilized Plasma Membrane 
Stimulating antigen 
% Specific cytotoxicity 
Target cells 
RBL-5  MBL-2  EdC,2  El-4 
Exp. I 
Exp. II 
RBL-5 cells  41  36  0  3 
RBL-5 PM  35  37  1  5 
RBL-5 solubilized PM  38  34  -  1  3 
RBL-5 cells  55  32  -2  ND* 
RBL-5 PM  45  30  -  I  ND 
RBL-5 solubilized PM  51  30  -  1  ND 
* ND, not done. 
report we present data indicating that the secondary generation of syngeneic cytotoxic 
effector cells with PM and SPM has been achieved. The specificity of the induction 
phase by PM and SPM, and of the effector phase by the cytotoxic cells generated was 
presented. We observed no difference in the specificity of these cells; all lysed syngeneic 
RBL-5 target cells and a cross-reacting tumor cell, MBL-2. Immunization with either 
RBL-5 or MBL-2 tumor cells will prevent the growth of a  subsequent challenge of 
either or both lymphomas. The antigens shared by the two tumors, which protected 
one against the other, have not been fully elucidated. It was suggested that the FMR 
group-specific antigens may be the common antigens recognized on these cells (13). 
E~G2, a syngeneic Gross virus-induced lymphoma was not lysed and the lysis of EL- 
4, a  chemically induced tumor was,  at best,  marginal.  EL-4 has been shown to be 
slightly contaminated with FMR group murine leukemia virus (14). 
The  ability  to  generate  syngeneic  cytotoxic lymphocytes with  SPM  should  be 
expected to make possible the study of the antigens involved in in vitro induction of 
cytotoxic cells and  those responsible for in  vivo tumor rejection. We have already 
obtained data which show that upon solubilization and chromatographic fractiona- 
tion of purified PM, the fractions that  induced cytotoxic effector cells in vitro also 
were able to protect against  an in vivo tumor challenge. 1 We believe that with this 
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approach,  the  elucidation  of  the  molecular  entity  of  TSTA  antigen 
ultimately feasible. 
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Summary 
Secondary induction of in vitro cytotoxic T  lymphocytes in a syngeneic system has 
been achieved with plasma membrane, both in the particulate and solubilized forms. 
Both the induction and the lytic phases were shown to be immunologically specific. 
The  effector  cells  generated  were  completely  susceptible  to  treatment  with  anti-0 
antibody and complement, suggesting that they are T  lymphocytes. 
Received for publication  17July  1978. 
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